Radiotherapy software firm RaySearch's Q2 sales, profit fall on delayed deals

RaySearch Laboratories AB (publ)

16/07/2026 14:15

Overview
Sweden medical software firm's preliminary Q2 net sales declined yr/yr, organic growth at -8%
Preliminary Q2 operating profit fell, mainly due to postponed U.S. deals
Order intake for Q2 rose compared to last year

Outlook
RaySearch expects strong performance in the second half of 2026
Company maintains operating margin target of at least 25% for 2026

Result Drivers
POSTPONED U.S. DEALS - Co said weaker Q2 sales and profit were mainly due to several U.S. deals being delayed, not lost

Company press release: ID:nMFN6d9ZnC

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
 
SEK 272 mln
 
Q2 Operating Profit
 
SEK 28 mln
 
Q2 Orders
 
SEK 296 mln

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)